Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors as well as in vivo gene therapy product candidates that address patient populations with high unmet medical need. The Company's approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System and nanoparticle and hybrid gene delivery technologies as well as in-house cell therapy manufacturing. The Company has formed a global strategic collaboration with Roche to unlock the promise of cell therapies for patients with hematological malignancies. Learn more at www.poseida.com.
View Top Employees from Poseida Therapeutics, Inc.| Website | http://poseida.com/ |
| Revenue | $32.7 million |
| Funding | $541.3 million |
| Employees | 336 (336 on RocketReach) |
| Founded | 2014 |
| Address | 9390 Towne Centre Dr 200, San Diego, California 92121, US |
| Phone | (858) 779-3100 |
| Technologies |
JavaScript,
HTML,
PHP
+53 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Genome Engineering, Business Services, Science and Engineering, CAR-T cells, Genetics, Gene Therapy, Health Care, Gene Editing, Medical Device, Therapeutics |
| Web Rank | 2 Million |
| Keywords | Cell Therapies, Gene Editing, Cancer Treatment, Rare Disease |
| Competitors | Adverum Biotechnologies, REGENXBIO Inc., Sorrento Therapeutics, Inc., Voyager Therapeutics, Inc. |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies |
Looking for a particular Poseida Therapeutics, Inc. employee's phone or email?
Poseida Therapeutics, Inc. Questions
The Poseida Therapeutics, Inc. annual revenue was $32.7 million in 2024.
336 people are employed at Poseida Therapeutics, Inc..
Poseida Therapeutics, Inc. is based in San Diego, California.
The NAICS codes for Poseida Therapeutics, Inc. are [541714, 5417, 54, 541, 54171].
The SIC codes for Poseida Therapeutics, Inc. are [873, 87].
Top Poseida Therapeutics, Inc. Employees
-
5+4
-
ViewKristin Yarema
President and Chief Executive Officer at Poseida Therapeutics, Inc.
Los Angeles, CA, US55 -
5+3
-
View
Loren Wagner
Senior Vice President, Global Operations at Poseida Therapeutics, Inc.
San Diego, CA, US12 -
View
Joshua Rychak
Vice President R and D, Gene Therapy at Poseida Therapeutics, Inc.
California, United States45+ -
View
Harry Leonhardt
General Counsel, Chief Compliance Officer and Corporate Secretary at Poseida Therapeutics, Inc.
San Diego, California, United States22 -
ViewLisa Portale
Senior Vice President Regulatory Affairs at Poseida Therapeutics, Inc.
San Diego, CA, US25+ -
21
-
12
Related Companies
